Virax Biolabs Group Ltd (VRAX) Total liabilities 2021–2025
Virax Biolabs Group Ltd (VRAX) total liabilities at each fiscal year-end, per SEC filings.
$730,783FY2025 · since FY2021: $690,303 → $730,783
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $730,783 | +523.5% |
| FY2024 | $117,212 | -82.9% |
| FY2023 | $686,002 | -33.0% |
| FY2022 | $1.0M | +48.2% |
| FY2021 | $690,303 | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice